William J. Newell

William J. Newell

Former Chief Executive OfficeratSutro Biopharma· In proxies 2022–2025

Pay in FY2025-28% from the year before · Sutro Biopharma stock -37.1% the same year

William J. Newell was paid $1.7M in FY2025 (Dec), down 28%. Sutro Biopharma stock fell 37.1% that year.

Pay$100 in the stock at the end of FY21 → $8
Pay is from the Summary Compensation Table of each Sutro Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Sutro BiopharmaPublic company · 4 yr
    • Former Chief Executive Officer2022 – Present · 4 yrStock in role -94%
  2. Biotechnology Innovation Organization’sPublic company
    • Director? – PresentNo stock prices for these years
  3. Emerging Company SectionPublic company
    • Director? – PresentNo stock prices for these years
  4. Health SectionPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?